**Core Concept**
Metabolic syndrome is a cluster of conditions that occur together, increasing the risk of developing type 2 diabetes and cardiovascular disease. It is characterized by central obesity, hypertension, elevated fasting glucose, high triglycerides, and low high-density lipoprotein (HDL) cholesterol levels.

**Why the Correct Answer is Right**
The correct answer is related to the antipsychotic medication atypical antipsychotics, which can cause weight gain and metabolic changes, leading to the development of metabolic syndrome. This is due to their antagonism of serotonin and dopamine receptors, which can increase appetite and food intake. Additionally, atypical antipsychotics can also increase insulin resistance and dyslipidemia, further contributing to the development of metabolic syndrome.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect as steroids are more commonly associated with Cushing's syndrome, which can also cause weight gain and metabolic changes, but is a distinct entity from metabolic syndrome.
* **Option B:** This option is incorrect as statins are lipid-lowering medications that can actually help improve lipid profiles and reduce the risk of cardiovascular disease, rather than contributing to metabolic syndrome.
* **Option D:** This option is incorrect as beta-blockers are medications that can help manage hypertension and cardiovascular disease, but are not typically associated with the development of metabolic syndrome.

**Clinical Pearl / High-Yield Fact**
It's essential for clinicians to monitor patients on atypical antipsychotics for weight gain and metabolic changes, and to consider switching to alternative medications or adding metabolic management strategies to reduce the risk of metabolic syndrome.

**Correct Answer:** C